Work

Biomarker studies in a phase I trial of DKN-01 in advanced esophageal cancer.

Year: 2017

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2017.35.4_suppl.161

Authors: John H. Strickler, Michael Kagey, Cynthia A. Sirard, Gabriel Dan Duda, Jorge Almenara, Celeste N. Powers, Johanna C. Bendell

Institutions: Duke Medical Center, Leap Therapeutics, Inc. (United States), Massachusetts General Hospital, Virginia Commonwealth University, Virginia Commonwealth University Medical Center, Sarah Cannon, Tennessee Oncology

Language: English

Topic: Esophageal Cancer Research and Treatment

Subfield: Surgery

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2599479941

Cites:

Cited by: 4

Related to: 10